© Copyright 2026 American Medical Association. All rights reserved.
The CPT® Code 80150 refers to the laboratory test for measuring Amikacin levels in the blood. Amikacin is classified as an injectable aminoglycoside antibiotic, primarily utilized in the treatment of severe or serious systemic bacterial infections caused by gram-negative organisms. The measurement of Amikacin levels is critical due to the drug's potential side effects, which include auditory and vestibular toxicity, renal toxicity, and the risk of neuromuscular blockade, which can lead to paralysis of muscles, including those essential for respiration. Monitoring blood levels of Amikacin is essential to ensure therapeutic efficacy while minimizing the risk of adverse effects. The test can be performed at random times or specifically at peak or trough levels, which are defined by specific timing relative to the administration of the drug. A random sample can be collected at any time, while peak levels are typically drawn 15 to 30 minutes after the completion of an intravenous infusion or 90 minutes after an intramuscular injection. Trough levels, on the other hand, are collected 30 minutes prior to the next dose of the drug. The blood sample for this test is obtained through a venipuncture, which is a separately reportable procedure. The serum from the blood sample is then analyzed using a fluorescence polarization immunoassay, a method that allows for accurate quantification of Amikacin levels in the bloodstream.
© Copyright 2026 Coding Ahead. All rights reserved.
Get instant expert-level answers from CasePilot, our coding assistant.
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Create a free account to unlock this content
Get instant expert-level medical coding assistance.